Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Clinical Therapeutics|May 7, 2013
Chemical sensitivity: pathophysiology or pathopsychology?Stephen J GenuisEuropean Journal of Internal Medicine|October 31, 2007
Clinical medicine and the budding science of indoor mold exposureStephen J GenuisReproductive Toxicology (Elmsford, N.Y.)|June 4, 2009
Nowhere to hide: Chemical toxicants and the unborn childStephen J GenuisJournal of Forensic Sciences|February 4, 2009
Toxicant exposure and mental health--individual, social, and public health considerationsStephen J GenuisHuman & Experimental Toxicology|April 20, 2010
Elimination of persistent toxicants from the human bodyStephen J GenuisPublic Health|June 19, 2007
Fielding a current idea: exploring the public health impact of electromagnetic radiationStephen J GenuisMuscle & Nerve|July 18, 2023
What do people affected by amyotrophic lateral sclerosis want from health communications? Evidence from the ALS Talk ProjectShelagh K Genuis, Westerly Luth, Tania Bubela, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 20, 2025
Patient-based evidence for amyotrophic lateral sclerosis prognostic health communication: "the clock is ticking…how long do I have?"Shelagh K Genuis, Westerly Luth, Brianna Adams, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 16, 2022
Amyotrophic lateral sclerosis (ALS) health charities are central to ALS care: perspectives of Canadians affected by ALSMira Ahmad, Shelagh K Genuis, Westerly Luth, et al.BMC Medical Research Methodology|October 6, 2023
Asynchronous online focus groups for research with people living with amyotrophic lateral sclerosis and family caregivers: usefulness, acceptability and lessons learnedShelagh K Genuis, Westerly Luth, Garnette Weber, et al.Pageof 8